PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial
AID  - 10.1136/jitc-2023-006871corr1
DP  - 2023 Jul 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e006871corr1
VI  - 11
IP  - 7
4099  - http://jitc.bmj.com/content/11/7/e006871corr1.short
4100  - http://jitc.bmj.com/content/11/7/e006871corr1.full
SO  - J Immunother Cancer2023 Jul 01; 11